Antimetabolites: all 7,305 studies that test it
Page 52 of 74. Open to participants first (1,098), then studies with results posted, then the rest; newest registration first within each.
- Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal DiseaseWithdrawnNCT01438021Not applicable
- Treatment of Relapsed or Refractory Acute Myeloblastic LeukemiaCompletedNCT01435343Phase 1/2
- Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary OriginTerminatedNCT01434459Phase 1
- Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and RadiotherapyCompletedNCT01434147Phase 2
- Epirubicin and Paclitaxel, Alone or Together With Capecitabine as First Line Treatment in Metastatic Breast CancerCompletedNCT01433614Phase 3
- Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic CancerCompletedNCT01430052Phase 2
- Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT01429961Phase 2
- S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric CancerStatus unknownNCT01426646Phase 2
- Combination Therapy of Gemcitabine and Trabectedin in L-sarcomasCompletedNCT01426633Phase 1
- Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01424709Phase 2
- Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic LeukaemiaStatus unknownNCT01423747Phase 3
- ALL-SCT BFM International- HSCT in Children and Adolescents With ALLStatus unknownNCT01423500Phase 3
- ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDSStatus unknownNCT01423175Phase 2
- Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML)CompletedNCT01422603Phase 1/2
- Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid MalignanciesCompletedNCT01421173Phase 1
- Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01417390Phase 2
- Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryCompletedNCT01416662Phase 2
- The Study of Metastatic Pancreatic AdenocarcinomaCompletedNCT01415713Phase 1/2
- AX Versus AC as Adjuvant Treatment for Node-Negative Breast CancerStatus unknownNCT01415336Phase 2/3
- Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML<60aStatus unknownNCT01414231Phase 3
- XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric CancerStatus unknownNCT01412294Phase 2
- Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas CancerStatus unknownNCT01411072Not applicable
- Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic LeukemiaTerminatedNCT01408160Phase 1
- 5fluorouracil for Advanced PhotoagingStatus unknownNCT01405144Phase 3
- SOX as Salvage Treatment in Nasopharyngeal CarcinomaTerminatedNCT01403259Phase 2
- Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase ExpressionStatus unknownNCT01401192Phase 2
- An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal CancerCompletedNCT01397305Phase 1/2
- Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable TumoursCompletedNCT01397019Phase 2
- Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic CancerCompletedNCT01396681Phase 2
- Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic CancerCompletedNCT01396668Phase 2
- Steroids and Azathioprine in Advanced IgANCompletedNCT01392833Phase 3
- Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell TransplantCompletedNCT01390311Phase 1
- Efficacy and Safety of a Neoadjuvant Treatment in Pancreatic CancerCompletedNCT01389440Phase 2
- Panitumumab Plus Gemcitabine and Oxaliplatin (GEMOX)Versus GEMOX Alone to Treat Advanced Biliary Tract AdenocarcinomaCompletedNCT01389414Phase 2
- A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid NeoplasmsCompletedNCT01387763Phase 3
- Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast CancerCompletedNCT01387373Phase 2
- Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal CancerCompletedNCT01386346Phase 1
- SOM 230 and Gemcitabine in Advanced Pancreatic CancerCompletedNCT01385956Phase 1
- Clove In The Treatment Of Relapsed Or Resistant Acute Leukemia In ChildrenCompletedNCT01385891Phase 2/3
- Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal CancerCompletedNCT01383343Phase 1
- Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC)CompletedNCT01380808Phase 2
- Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal CancerCompletedNCT01376453Phase 1
- Antiglucocorticoid Augmentation of antiDepressants in DepressionCompletedNCT01375920Phase 3
- Intensified Rituimab Prephase Before FCR in Untreated B-CLLCompletedNCT01370772Phase 2
- New Treatment Option for Pancreatic CancerCompletedNCT01364805Phase 1
- A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric CancerCompletedNCT01364493Phase 2
- S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Calcium Plus Oxaliplatin as Perioperative Chemotherapy for Advanced Gastric CarcinomaCompletedNCT01364376Not applicable
- EMD 1201081 + 5-FU + Cisplatin + Cetuximab in Subjects With Recurrent / Metastatic Squamous Cell Carcinoma of the Head and NeckTerminatedNCT01360827Phase 1
- Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal JunctionCompletedNCT01360086Phase 2
- A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or LymphomaCompletedNCT01359696Phase 1
- Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric CancerStatus unknownNCT01359397Phase 2
- Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung CancerTerminatedNCT01356368Phase 2
- Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and PlaceboCompletedNCT01354717Phase 3
- TAC Versus TCX as Adjuvant Treatment for High-risk Her2-Negative Breast CancerCompletedNCT01354522Phase 3
- Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid TumorsCompletedNCT01352962Phase 1
- Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML)CompletedNCT01352650Phase 1
- Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast CancerStatus unknownNCT01352494Phase 2
- Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric AdenocarcinomaTerminatedNCT01351038Phase 2
- Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast CancerWithdrawnNCT01349088Phase 1/2
- Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy FailureCompletedNCT01348412Phase 2
- Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis PatientsCompletedNCT01347983Phase 3
- The Effect of Single Dose D-Cycloserine on Cognitive Outcome in Moderate Traumatic Brain Injury (TBI) PatientsStatus unknownNCT01343862Phase 2
- Study of Vidaza (Azacitidine) Versus Support Treatment in Patients With Low Risk Myelodysplastic Syndrome (Low and Intermediate-1 IPSS) Without the 5q Deletion and Transfusion Dependent AnaemiaCompletedNCT01338337Phase 2
- Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid TumorsCompletedNCT01336842Phase 1
- Consolidation Chemotherapy/Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC)WithdrawnNCT01336543Phase 2
- Maintenance Gemcitabine in the Chinese Advanced Lung CancerStatus unknownNCT01336192Phase 4
- Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and NeckStatus unknownNCT01333696Phase 2
- Study of Decitabine Induction Prior to Allogeneic Hematopoietic Cell Transplant in Newly Diagnosed MDS PatientsTerminatedNCT01333449Phase 2
- Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas CancerStatus unknownNCT01333332Phase 2
- Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric CancerStatus unknownNCT01331928Phase 2
- Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)CompletedNCT01326559Phase 2
- CHemoImmunotherapy With Early Central Nervous System (CNS) ProphylaxisCompletedNCT01325194Phase 2
- Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic SyndromesWithdrawnNCT01324960Phase 1/2
- Trial of GSK1120212 and GSK1120212 in Combination With GEM in Japanese Subjects With Solid TumorsCompletedNCT01324258Phase 1
- Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal CancerCompletedNCT01322152Phase 2
- PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)CompletedNCT01320254Phase 2
- A Randomized, Open, Prospective Clinical Research of Fluorouracil Implant to Improve Surgical Gallbladder Cancer and Bile Duct CancerStatus unknownNCT01317069Phase 2
- A Study of Tesetaxel Plus Capecitabine in Patients With Solid TumorsStatus unknownNCT01315431Phase 1
- Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic CancerTerminatedNCT01314027Phase 3
- Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by SurgeryCompletedNCT01313377Phase 3
- Initiation of Allopurinol at First Medical Contact for Acute Attacks of GoutCompletedNCT01310673Phase 4
- Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)CompletedNCT01309633Phase 2
- Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in T2-T3s N0, M0 Rectal CancerCompletedNCT01308190Phase 3
- Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon CancerStatus unknownNCT01308086Phase 3
- Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin LymphomaStatus unknownNCT01307592Phase 2
- Intensified Azacitidine in High Risk Myelodysplastic Syndrome (MDS)CompletedNCT01305460Phase 1/2
- Idarubicin Combined to Azacitidine in Int-2 or High Risk Myelodysplastic SyndromesCompletedNCT01305135Phase 1/2
- A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive CancerCompletedNCT01304784Phase 1
- A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly PatientsCompletedNCT01303887Phase 3
- Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic CancerCompletedNCT01303029Phase 2
- Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal AdenocarcinomaWithdrawnNCT01302613Phase 1/2
- Study of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic SyndromesWithdrawnNCT01302106Phase 2
- Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)CompletedNCT01301820Phase 2
- Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the PancreasCompletedNCT01298401Phase 1
- Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic CancerCompletedNCT01298011Phase 2
- A Phase I Study of Adjuvant Chemotherapy With GC in Biliary Tract Cancer Undergoing Resection Without Major HepatectomyCompletedNCT01297998Phase 1
- Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)Status unknownNCT01295593Phase 1/2
- Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)CompletedNCT01295307Phase 2
- Keloid Scarring: Treatment and PathophysiologyWithdrawnNCT01295099Phase 4
- Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable CancerCompletedNCT01295086Not applicable